Skip to main content

Table 1 Patients' characteristics and other factor

From: The effects of fentanyl, oxycodone, and butorphanol on gastrointestinal function in patients undergoing laparoscopic hysterectomy: a prospective, double-blind, randomized controlled trial

 

Group F (n = 39)

Group O (n = 36)

Group B (n = 37)

Age (y)

52.5 ± 6.6

51.4 ± 6.7

51.4 ± 6.9

Height (cm)

159.7 ± 4.6

159.1 ± 4.0

160.2 ± 4.2

Weight (kg)

60 (55–72)

60 (60–68)

60 (56–74)

BMI (kg/m2)

24.7 (22.1–25.8)

24.9 (23.4–26.5)

23.4 (22–25)

ASA status

   

I [n (%)]

4 (10.3)

3 (8.3)

2 (5.4)

II [n (%)]

35 (89.7)

33 (91.7)

35 (94.6)

Diagnosis

   

Cancer [n (%)]

18 (46.2)

15 (41.7)

18 (48.6)

CIN [n (%)]

12 (30.8)

14 (38.9)

9 (24.4)

Uterine fibroids [n (%)]

6 (15.3)

3 (8.3)

7 (18.9)

Adenomyosis [n (%)]

3 (7.7)

4 (11.1)

3 (8.1)

Duration of surgery (min)

132 (100–193)

125 (90–159)

115 (90–140)

Duration of anesthesia (min)

162 (120–235)

153(121–185)

140 (112–165)

Consumption of fentanyl (mg)

0.55 (0.50–0.65)

0.60 (0.50–0.60)

0.55 (0.50–0.60)

Total fluid (mL)

2100 (1600–2675)

2100 (1975–2500)

2000 (1600–2600)

Total loss (mL)

300 (200–507)

250 (150–400)

250 (150–388)

Leukocyte count (*109/L)

5.7 (4.7–7.3)

5.3 (4.7–6.6)

5.2 (4.4–6)

Percentage of neutrophils (%)

56.3 (51.6–64.2)

56.3 (51.4–64.5)

56.5 (52.3–60.1)

Potassium (mmol/L)

3.8 (3.5–4.0)

3.8 (3.5–4.0)

3.8 (3.6–4.0)

  1. Table legends: Normally distributed data are presented as mean ± SD, which were analyzed using ANOVA; non-normal data are presented as median (range), which were analyzed using Kruskal–Wallis H-test; categorical variables are presented as count (%), which were analyzed using the χ2 test and Fisher’s exact test
  2. Abbreviations: ASA American Society of Anesthesiologists, ANOVA  one-way analysis of variance, BMI  body mass index, B  butorphanol, CIN  cervical intraepithelial neoplasia, F  fentanyl, O  oxycodone, SD  standard deviation